Travere Therapeutics, Inc. Board of Directors

Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases. Its products include FILSPARI (sparsentan), a once-daily, oral medication designed to target two critical pathways in the disease progression of IgA Nephropathy (endothelin 1 and angiotensin-II); and Thiola and Thiola EC (tiopronin tablets) for the treatment of cystinuria, a rare genetic cystine transport disorder that causes high cystine levels in the urine and the formation of recurring kidney stones. The company's clinical-stage programs consist of Sparsentan, a novel investigational product candidate, which has been granted Orphan Drug Designation for the treatment of focal segmental glomerulosclerosis in the U.S. and Europe; and Pegtibatinase (TVT-058), a novel investigational human enzyme replacement candidate being evaluated for the treatment of classical homocystinuria. It has a cooperative research and development agreement with National Institutes of Health's National Center for Advancing Translational Sciences and Alagille Syndrome Alliance for the identification of potential small molecule therapeutics for Alagille syndrome. The company was formerly known as Retrophin, Inc. and changed its name to Travere Therapeutics, Inc. in November 2020. Travere Therapeutics, Inc. was incorporated in 2008 and is headquartered in San Diego, California.

Dr. Eric M. Dube Ph.D.

Dr. Eric M. Dube Ph.D.

President, CEO & Director

Mr. Casey Logan

Mr. Casey Logan

Chief Business Officer

Ms. Nivi Nehra

Ms. Nivi Nehra

Vice President of Corporate Communications & Investor Relations

Dr. Jula Inrig M.D.

Dr. Jula Inrig M.D.

Chief Medical Officer

Ms. Sandra Calvin

Ms. Sandra Calvin

SVP, Corporate Controller & Chief Accounting Officer

Dr. William E. Rote Ph.D.

Dr. William E. Rote Ph.D.

Senior VP and Head of Research & Development

Ms. Elizabeth E. Reed J.D.

Ms. Elizabeth E. Reed J.D.

Senior VP, General Counsel & Corporate Secretary

Ms. Angela Giannantonio

Ms. Angela Giannantonio

Senior Vice President of Human Resources

Mr. Peter Heerma

Mr. Peter Heerma

Chief Commercial Officer

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.